TAM
ACOR

Tocqueville Asset Management’s Acorda Therapeutics ACOR Stock Holding History

Tocqueville Asset Management’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-125
Closed -$500K – 1017
2015
Q2 		$500K Hold
125
– – 0.01% 719
2015
Q1 		$499K Hold
125
– – 0.01% 718
2014
Q4 		$613K Hold
125
– – 0.01% 666
2014
Q3 		$508K Hold
125
– – 0.01% 618
2014
Q2 		$506K Buy
125
+8
+7% +$32.6K ﹤0.01% 721
2014
Q1 		$531K Buy
117
+34
+41% +$137K 0.01% 559
2013
Q4 		$292K Buy
+83
New +$324K ﹤0.01% 717

Other funds holding ACOR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Tocqueville Asset Management's ACOR Position: Q3 2015 in Review

Tocqueville Asset Management sold out of Acorda Therapeutics (ACOR) in Q3 2015, closing a stake of 125 shares — an estimated $500K sold.

Tocqueville Asset Management first reported a position in ACOR in Q4 2013 and held it in 7 quarters. The position peaked at $613K in Q4 2014. 176 funds tracked by Wall St. Rank hold ACOR as of Q3 2015.

  • Tocqueville Asset Management reported no remaining Acorda Therapeutics position as of Q3 2015 after selling out during the quarter.
  • Tocqueville Asset Management sold 125 Acorda Therapeutics shares in Q3 2015, an estimated $500K.
  • Tocqueville Asset Management first reported a position in Acorda Therapeutics in Q4 2013 and held it in 7 quarters.
  • Tocqueville Asset Management's Acorda Therapeutics position peaked at $613K in Q4 2014.
  • 176 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q3 2015.

Based on Tocqueville Asset Management's 13F filing for Q3 2015, filed 30 Oct 2015.